(Q37617838)

21 August 2017

1 reference

title

Histology and molecular pathology of pediatric brain tumors (English)

1 reference

21 August 2017

0 references

Stefan Pfister

1

0 references

Andrey Korshunov

series ordinal

3

object named as

Andrey Korshunov

1 reference

21 August 2017

Christian Hartmann

2

1 reference

21 August 2017

publication date

1 November 2009

1 reference

Journal of Child Neurology

21 August 2017

published in

1 reference

21 August 2017

volume

24

1 reference

21 August 2017

issue

11

1 reference

21 August 2017

page(s)

1375-1386

1 reference

Population-based epidemiologic data on brain tumors in German children

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

The 2007 WHO classification of tumours of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

A population-based study of the incidence and survival rates in patients with pilocytic astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Clinical and molecular characteristics of malignant transformation of low-grade glioma in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

RAS pathway activation and an oncogenic RAS mutation in sporadic pilocytic astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

High-resolution, dual-platform aCGH analysis reveals frequent HIPK2 amplification and increased expression in pilocytic astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Expression of p53 and prognosis in children with malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Diffuse brainstem glioma in children: critical review of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Brainstem tumors: where are we today?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

The treatment of high grade gliomas and diffuse intrinsic pontine tumors of childhood and adolescence: a historical - and futuristic - perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Stepwise accumulation of distinct genomic aberrations in a patient with progressively metastasizing ependymoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Correlation between 6q25.3 deletion status and survival in pediatric intracranial ependymomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Radial glia cells are candidate stem cells of ependymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

21 January 2018

Choroid plexus tumours

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

High-resolution array-based comparative genomic hybridization of medulloblastomas and supratentorial primitive neuroectodermal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Array CGH analysis of pediatric medulloblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

FOXG1 dysregulation is a frequent event in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Prediction of central nervous system embryonal tumour outcome based on gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Supratentorial primitive neuroectodermal tumors of the central nervous system frequently harbor deletions of the CDKN2A locus and other genomic aberrations distinct from medulloblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumours of the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

No evidence for hypermethylation of the hSNF5/INI1 promoter in pediatric rhabdoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339213

21 January 2018

Identifiers

DOI

10.1177/0883073809339213

1 reference

21 August 2017

1 reference